Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy Study of Anyu Peibo in the Treatment of Major Depressive Disorder(MDD): a Ⅱb Stratified Randomized, Double-Blind, Placebo-Paralleled, Multicenter Clinical Trial

NCT03183505 is registered in ClinicalTrials.gov with Shanghai Mental Health Center as lead sponsor.

NCT NCT03183505
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03183505 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy Study of Anyu Peibo in the Treatment of Major Depressive Disorder(MDD): a Ⅱb Stratified Randomized, Double-Blind, Placebo-Paralleled, Multicenter Clinical Trial
Lead sponsor
Shanghai Mental Health Center
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2017
Completion date
November 29, 2018
Enrollment
172 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder